ReviewCureus2025
Diagnostic Disparities in Erythema Visibility: A Call to Redefine Inflammatory Assessment in Diverse Skin Tones.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Placebo Response in Randomised Controlled Trials of Systemic Therapies for Cutaneous Lupus Erythematosus: A Systematic Review and Meta-Analysis.Pharmaceutical medicine · 2026Pooled it
- Pyoderma gangrenosum in a 26-year-old woman.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026Article
- Lightning Strike-Induced Cutaneous Burns and Airway Injury: A Case Report Highlighting Recurrent Extubation Failure in a Critically Ill Patient.European burn journal · 2026Article
- Quantifying Erythema and Skin Tone Variation in Cutaneous Rashes: A Colorimetric Approach.Cureus · 2026Article
- The cutaneous mirror: leveraging drug-induced skin phenotypes as early visual risk signals for systemic toxicity, a comprehensive review.Frontiers in drug safety and regulation · 2026Review
- Diagnostic Accuracy of Artificial Intelligence Applications on a Diverse Skin Image Set.Cureus · 2026Article
- Case Report: Flagellate eruption of adult-onset still disease in an Afro-Caribbean woman: highlighting atypical cutaneous disease in richly pigmented skin.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disparities in the diagnosis of erythema across different skin tones present a significant barrier to equitable dermatologic care. These disparities arise from a focus on lighter skin tones in clinical training and diagnostic criteria, leading to challenges in accurately identifying erythema in individuals with Fitzpatrick skin types IV to VI. Redness associated with vasodilation may not be visibly apparent or can manifest differently on darker skin, resulting in underdiagnosis or misclassification of inflammatory skin conditions. Current assessment tools, like the Investigator's Global Assessment (IGA) and the Eczema Area and Severity Index (EASI), emphasize visible erythema and lack validated alternatives for variations in pigmentation. To promote diagnostic equity, there is a need to update inflammatory assessment methods by integrating objective metrics such as high-frequency ultrasound and infrared imaging, while also developing new training protocols that include diverse skin representations. By redefining erythema with inclusive terminology and incorporating diverse datasets in machine-learning tools, we can enhance diagnostic accuracy and ensure equitable care in inflammatory dermatology for all populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.